These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 17629667)

  • 21. Predictive model for survival in patients with advanced cancer.
    Chow E; Abdolell M; Panzarella T; Harris K; Bezjak A; Warde P; Tannock I
    J Clin Oncol; 2008 Dec; 26(36):5863-9. PubMed ID: 19018082
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The MELD-Na is an independent short- and long-term prognostic predictor for hepatocellular carcinoma: a prospective survey.
    Huo TI; Lin HC; Hsia CY; Huang YH; Wu JC; Chiang JH; Chiou YY; Lui WY; Lee PC; Lee SD
    Dig Liver Dis; 2008 Nov; 40(11):882-9. PubMed ID: 18339595
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Consensus or data-derived anatomic injury severity scoring?
    Moore L; Lavoie A; Le Sage N; Bergeron E; Emond M; Abdous B
    J Trauma; 2008 Feb; 64(2):420-6. PubMed ID: 18301208
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Quality of life before intensive care unit admission is a predictor of survival.
    Hofhuis JG; Spronk PE; van Stel HF; Schrijvers AJ; Bakker J
    Crit Care; 2007; 11(4):R78. PubMed ID: 17629906
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An Australian risk prediction model for 30-day mortality after isolated coronary artery bypass: the AusSCORE.
    Reid C; Billah B; Dinh D; Smith J; Skillington P; Yii M; Seevanayagam S; Mohajeri M; Shardey G
    J Thorac Cardiovasc Surg; 2009 Oct; 138(4):904-10. PubMed ID: 19660369
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prediction model for estimating the survival benefit of adjuvant radiotherapy for gallbladder cancer.
    Wang SJ; Fuller CD; Kim JS; Sittig DF; Thomas CR; Ravdin PM
    J Clin Oncol; 2008 May; 26(13):2112-7. PubMed ID: 18378567
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Plasminogen activation inhibitor-1 improves the predictive accuracy of prostate cancer nomograms.
    Shariat SF; Park S; Trinh QD; Roehrborn CG; Slawin KM; Karakiewicz PI
    J Urol; 2007 Oct; 178(4 Pt 1):1229-36; discussion 1236-7. PubMed ID: 17698116
    [TBL] [Abstract][Full Text] [Related]  

  • 28. External validation of a biomarker-based preoperative nomogram predicts biochemical recurrence after radical prostatectomy.
    Shariat SF; Walz J; Roehrborn CG; Zlotta AR; Perrotte P; Suardi N; Saad F; Karakiewicz PI
    J Clin Oncol; 2008 Mar; 26(9):1526-31. PubMed ID: 18349404
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long-term prediction of prostate cancer: prostate-specific antigen (PSA) velocity is predictive but does not improve the predictive accuracy of a single PSA measurement 15 years or more before cancer diagnosis in a large, representative, unscreened population.
    Ulmert D; Serio AM; O'Brien MF; Becker C; Eastham JA; Scardino PT; Björk T; Berglund G; Vickers AJ; Lilja H
    J Clin Oncol; 2008 Feb; 26(6):835-41. PubMed ID: 18281654
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Development and validation of a prognostic scale for use in patients with advanced cancer.
    Stone P; Kelly L; Head R; White S
    Palliat Med; 2008 Sep; 22(6):711-7. PubMed ID: 18715969
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The newer the better? Comparison of the 1997 and 2001 partin tables for pathologic stage prediction of prostate cancer in China.
    Gao X; Ren S; Lu X; Xu C; Sun Y
    Urology; 2008 Nov; 72(5):1096-101. PubMed ID: 18822453
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A new prognostic score system in patients with advanced hepatocellular carcinoma not amendable to locoregional therapy: implication for patient selection in systemic therapy trials.
    Yau T; Yao TJ; Chan P; Ng K; Fan ST; Poon RT
    Cancer; 2008 Nov; 113(10):2742-51. PubMed ID: 18853421
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of the prognostic value of a panel of tissue tumor markers and established clinicopathological factors in patients with gastric cancer.
    Wiksten JP; Lundin J; Nordling S; Kokkola A; Haglund C
    Anticancer Res; 2008; 28(4C):2279-87. PubMed ID: 18751407
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A simple and accurate model for prediction of cancer-specific mortality in patients treated with surgery for primary penile squamous cell carcinoma.
    Zini L; Cloutier V; Isbarn H; Perrotte P; Capitanio U; Jeldres C; Shariat SF; Saad F; Arjane P; Duclos A; Lattouf JB; Montorsi F; Karakiewicz PI
    Clin Cancer Res; 2009 Feb; 15(3):1013-8. PubMed ID: 19188173
    [TBL] [Abstract][Full Text] [Related]  

  • 35. B-type natriuretic peptide as a marker for sepsis-induced myocardial depression in intensive care patients.
    Post F; Weilemann LS; Messow CM; Sinning C; Münzel T
    Crit Care Med; 2008 Nov; 36(11):3030-7. PubMed ID: 18824903
    [TBL] [Abstract][Full Text] [Related]  

  • 36. PIEPOC: a new prognostic index for advanced epithelial ovarian cancer--Japan Multinational Trial Organization OC01-01.
    Teramukai S; Ochiai K; Tada H; Fukushima M;
    J Clin Oncol; 2007 Aug; 25(22):3302-6. PubMed ID: 17664478
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Using the Palliative Performance Scale to provide meaningful survival estimates.
    Lau F; Downing M; Lesperance M; Karlson N; Kuziemsky C; Yang J
    J Pain Symptom Manage; 2009 Jul; 38(1):134-44. PubMed ID: 19171459
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Multiple biomarkers improve prediction of bladder cancer recurrence and mortality in patients undergoing cystectomy.
    Shariat SF; Karakiewicz PI; Ashfaq R; Lerner SP; Palapattu GS; Cote RJ; Sagalowsky AI; Lotan Y
    Cancer; 2008 Jan; 112(2):315-25. PubMed ID: 18008359
    [TBL] [Abstract][Full Text] [Related]  

  • 39. PSA kinetics provide improved prediction of survival in metastatic hormone-refractory prostate cancer.
    Robinson D; Sandblom G; Johansson R; Garmo H; Aus G; Hedlund PO; Varenhorst E;
    Urology; 2008 Oct; 72(4):903-7. PubMed ID: 18639324
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Validation of the Seattle Heart Failure Model in a community-based heart failure population and enhancement by adding B-type natriuretic peptide.
    May HT; Horne BD; Levy WC; Kfoury AG; Rasmusson KD; Linker DT; Mozaffarian D; Anderson JL; Renlund DG
    Am J Cardiol; 2007 Aug; 100(4):697-700. PubMed ID: 17697831
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.